Douglas Miehm
Stock Analyst at RBC Capital
(1.91)
# 3,066
Out of 4,884 analysts
43
Total ratings
40.54%
Success rate
-9.15%
Average return
Main Sectors:
Stocks Rated by Douglas Miehm
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BHC Bausch Health Companies | Maintains: Sector Perform | $8.5 → $10 | $7.06 | +41.64% | 20 | May 2, 2025 | |
| BLCO Bausch + Lomb | Maintains: Outperform | $18 → $17 | $13.88 | +22.48% | 13 | Apr 4, 2025 | |
| ONCY Oncolytics Biotech | Maintains: Outperform | $6 → $5 | $0.92 | +443.54% | 1 | Mar 10, 2025 | |
| AUPH Aurinia Pharmaceuticals | Maintains: Outperform | $13 → $8 | $7.59 | +5.40% | 9 | Feb 16, 2024 |
Bausch Health Companies
May 2, 2025
Maintains: Sector Perform
Price Target: $8.5 → $10
Current: $7.06
Upside: +41.64%
Bausch + Lomb
Apr 4, 2025
Maintains: Outperform
Price Target: $18 → $17
Current: $13.88
Upside: +22.48%
Oncolytics Biotech
Mar 10, 2025
Maintains: Outperform
Price Target: $6 → $5
Current: $0.92
Upside: +443.54%
Aurinia Pharmaceuticals
Feb 16, 2024
Maintains: Outperform
Price Target: $13 → $8
Current: $7.59
Upside: +5.40%